483
Hugel Inc.Hugel Inc. – FDA 483, Feb 1, 2024
Record Details
Hugel, Inc., a drug substance and drug product manufacturer in Chuncheon, Korea, received two observations during an FDA inspection. The firm was cited for not establishing and following procedures to prevent microbiological contamination of sterile drug products, specifically concerning media fills. Additionally, visual inspection procedures were found to be inadequate, particularly regarding ambient lighting.
View Company Profile
ID · 6b694a3e-ecef-44c5-a2d4-8713fa0d0ef2
Other documents for Hugel Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.